Cancer Vanguard 23 October 2017
- UCLH Cancer Collaborative has partnered with Amgen to develop a simulation modelling tool that allows multiple delivery pathways of denosumab (whether in hospital, in primary care, in the community or at home) to be to be tested for financial and patient experience impact.
- An options appraisal document and user guide will accompany the model in a toolkit available to all NHS Trusts and CCGs.
- The project toolkit is accessible to NHS staff with an NHS email address.
- Register here to access the materials.
